Follow
Zainab Mohammed Elsayed
Zainab Mohammed Elsayed
Scientific research and innovation support unit
Verified email at std.pharma.cu.edu.eg
Title
Cited by
Cited by
Year
3-Methylthiazolo [3, 2-a] benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and …
AAM Alkhaldi, MM Al-Sanea, A Nocentini, WM Eldehna, ZM Elsayed, ...
European Journal of Medicinal Chemistry 207, 112745, 2020
532020
Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria
ZM Elsayed, WM Eldehna, MM Abdel-Aziz, MA El Hassab, EB Elkaeed, ...
Journal of enzyme inhibition and medicinal chemistry 36 (1), 384-392, 2021
442021
Benzofuran-based carboxylic acids as carbonic anhydrase inhibitors and antiproliferative agents against breast cancer
WM Eldehna, A Nocentini, ZM Elsayed, T Al-Warhi, N Aljaeed, OJ Alotaibi, ...
ACS Medicinal Chemistry Letters 11 (5), 1022-1027, 2020
432020
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors
M Shaldam, WM Eldehna, A Nocentini, ZM Elsayed, TM Ibrahim, R Salem, ...
European Journal of Medicinal Chemistry 216, 113283, 2021
402021
Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4, 5-dihydropyrazoles as anticancer agents with potential EGFR …
WM Eldehna, MA El Hassab, ZM Elsayed, T Al-Warhi, H Elkady, ...
Scientific reports 12 (1), 12821, 2022
392022
Design, synthesis and biological evaluation of new HDAC1 and HDAC2 inhibitors endowed with ligustrazine as a novel cap moiety
MM Al-Sanea, L Gotina, MFA Mohamed, D Grace Thomas Parambi, ...
Drug design, development and therapy, 497-508, 2020
372020
Development of novel benzofuran-isatin conjugates as potential antiproliferative agents with apoptosis inducing mechanism in Colon cancer
WM Eldehna, R Salem, ZM Elsayed, T Al-Warhi, HR Knany, RR Ayyad, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1423-1434, 2021
262021
Development of 3-methyl/3-(morpholinomethyl) benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells
MM Al-Sanea, GH Al-Ansary, ZM Elsayed, RM Maklad, EB Elkaeed, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 987-999, 2021
212021
Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens
T Al-Warhi, DM Elimam, ZM Elsayed, MM Abdel-Aziz, RM Maklad, ...
RSC advances 12 (48), 31466-31477, 2022
192022
Development of novel quinoline-based sulfonamides as selective cancer-associated carbonic anhydrase isoform IX inhibitors
M Shaldam, A Nocentini, ZM Elsayed, TM Ibrahim, R Salem, ...
International Journal of Molecular Sciences 22 (20), 11119, 2021
172021
Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis
WM Eldehna, MA El Hassab, NA Abdelshafi, FAZ Sayed, M Fares, ...
International Journal of Pharmaceutics 612, 121369, 2022
162022
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
MA Shaldam, H Almahli, A Angeli, RM Badi, EF Khaleel, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2203389, 2023
152023
Novel 2-(5-Aryl-4, 5-dihydropyrazol-1-yl) thiazol-4-one as EGFR inhibitors: synthesis, biological assessment and molecular docking insights
T Al-Warhi, AM El Kerdawy, MA Said, A Albohy, ZM Elsayed, N Aljaeed, ...
Drug Design, Development and Therapy, 1457-1471, 2023
142023
Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease
MH ElNaggar, AA Elgazar, G Gamal, SM Hamed, ZM Elsayed, ...
Journal of enzyme inhibition and medicinal chemistry 38 (1), 2234665, 2023
72023
1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights
T Al-Warhi, H Almahli, RM Maklad, ZM Elsayed, MA El Hassab, ...
Molecules 28 (7), 3203, 2023
72023
Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors
WM Eldehna, MA El Hassab, NA Abdelshafi, RA Eissa, NH Diab, ...
International Journal of Pharmaceutics 631, 122537, 2023
72023
Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors
ZM Elsayed, H Almahli, A Nocentini, A Ammara, CT Supuran, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2191163, 2023
52023
Computational Prediction of the Potential Target of SARS‐CoV‐2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM‐PBSA Calculations
MA El Hassab, LR Hemeda, ZM Elsayed, ST Al‐Rashood, ...
Chemistry & Biodiversity 19 (2), e202100719, 2022
52022
Phthalimide‐tethered isatins as novel poly (ADP‐ribose) polymerase inhibitors: Design, synthesis, biological evaluations, and molecular modeling investigations
MA El Hassab, AAA El‐Hafeez, H Almahli, ZM Elsayed, WM Eldehna, ...
Archiv der Pharmazie 357 (3), 2300599, 2024
32024
Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis
T Al‐Warhi, NM Rashad, H Almahli, MM Abdel‐Aziz, ZM Elsayed, ...
Archiv der Pharmazie 357 (2), 2300529, 2024
22024
The system can't perform the operation now. Try again later.
Articles 1–20